Cargando…
Structure–Activity Relationship Studies on Novel Antiviral Agents for Norovirus Infections
Human norovirus is the leading cause of acute gastroenteritis worldwide, affecting every year 685 million people. Norovirus outbreaks are associated with very significant economic losses, with an estimated societal cost of 60 billion USD per year. Despite this, no therapeutic options or vaccines are...
Autores principales: | Ferla, Salvatore, Varricchio, Carmine, Knight, William, Ho, Pui Kei, Saporito, Fabiana, Tropea, Beatrice, Fagan, Giulio, Flude, Ben Matthew, Bevilacqua, Federica, Santos-Ferreira, Nanci, Van Dycke, Jana, Neyts, Johan, Brancale, Andrea, Rocha-Pereira, Joana, Bassetto, Marcella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468020/ https://www.ncbi.nlm.nih.gov/pubmed/34576691 http://dx.doi.org/10.3390/microorganisms9091795 |
Ejemplares similares
-
A new antiviral scaffold for human norovirus identified with computer-aided approaches on the viral polymerase
por: Giancotti, Gilda, et al.
Publicado: (2019) -
Targeting the Viral Polymerase of Diarrhea-Causing Viruses as a Strategy to Develop a Single Broad-Spectrum Antiviral Therapy
por: Bassetto, Marcella, et al.
Publicado: (2019) -
Structural Investigations on Novel Non-Nucleoside Inhibitors of Human Norovirus Polymerase
por: Giancotti, Gilda, et al.
Publicado: (2022) -
In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase
por: Ferla, Salvatore, et al.
Publicado: (2018) -
Current and Future Antiviral Strategies to Tackle Gastrointestinal Viral Infections
por: Santos-Ferreira, Nanci, et al.
Publicado: (2021)